Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-23

Clinical Trial Update: A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating an intermittent dosing regimen of fluticasone propionate 0.05% cream added to daily moisturization in pediatric stabilized a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate 0.05% cream (fluticasone propionate)
  • PHYSIOGEL Lotion

Snippet

Sponsor: GlaxoSmithKline | Conditions: Skin Diseases | Phase 4 | Status: COMPLETED | Results posted: 2015-12-23